» Articles » PMID: 39343894

Enzyme-armed Nanocleaner Provides Superior Detoxification Against Organophosphorus Compounds Via a Dual-action Mechanism

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2024 Sep 29
PMID 39343894
Authors
Affiliations
Soon will be listed here.
Abstract

By inhibiting acetylcholinesterase (AChE) activity, organophosphate compounds (OPs) can quickly cause severe injury to the nervous system and death, making it extremely difficult to rescue victims after OP exposure. However, it is quite challenging to construct scavengers that neutralize and eliminate these harmful chemical agents promptly in the blood circulation system. Herein, we report an enzyme-armed biomimetic nanoparticle that enables a 'targeted binding and catalytic degradation' action mechanism designed for highly efficient in vivo detoxification (denoted as 'Nanocleaner'). Specifically, the resulting Nanocleaner is fabricated with polymeric cores camouflaged with a modified red blood cell membrane (RBC membrane) that is inserted with the organophosphorus hydrolase (OPH) enzyme. In such a subtle construct, Nanocleaner inherits abundant acetylcholinesterase (AChE) on the surface of the RBC membrane, which can specifically lure and neutralize OPs through biological binding. The OPH enzyme on the membrane surface breaks down toxicants catalytically. The in vitro protective effects of Nanocleaner against methyl paraoxon (MPO)-induced inhibition of AChE activity were validated using both preincubation and competitive regimens. Furthermore, we selected the PC12 neuroendocrine cell line as an experimental model and confirmed the cytoprotective effects of Nanocleaner against MPO. In mice challenged with a lethal dose of MPO, Nanocleaner significantly reduces clinical signs of intoxication, rescues AChE activity and promotes the survival rate of mice challenged with lethal MPO. Overall, these results suggest considerable promise of enzyme-armed Nanocleaner for the highly efficient removal of OPs for clinical treatment.

References
1.
Xu W, Cai X, Wu Y, Wen Y, Su R, Zhang Y . Biomimetic single Al-OH site with high acetylcholinesterase-like activity and self-defense ability for neuroprotection. Nat Commun. 2023; 14(1):6064. PMC: 10539540. DOI: 10.1038/s41467-023-41765-x. View

2.
Efremenko E, Lyagin I, Klyachko N, Bronich T, Zavyalova N, Jiang Y . A simple and highly effective catalytic nanozyme scavenger for organophosphorus neurotoxins. J Control Release. 2017; 247:175-181. DOI: 10.1016/j.jconrel.2016.12.037. View

3.
Almeida J, Chen A, Foster A, Drezek R . In vivo biodistribution of nanoparticles. Nanomedicine (Lond). 2011; 6(5):815-35. DOI: 10.2217/nnm.11.79. View

4.
Bigley A, Xu C, Henderson T, Harvey S, Raushel F . Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis. J Am Chem Soc. 2013; 135(28):10426-32. PMC: 3747228. DOI: 10.1021/ja402832z. View

5.
Chao M, Weissman I, Majeti R . The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol. 2012; 24(2):225-32. PMC: 3319521. DOI: 10.1016/j.coi.2012.01.010. View